Do women benefit more from systemic thrombolysis in acute ischemic stroke? A Serbian experience with thrombolysis in ischemic stroke (SETIS) study

被引:31
作者
Jovanovic, D. R. [1 ]
Beslac-Bumbasirevic, Lj. [1 ]
Budimkic, M. [1 ]
Pekmezovic, T. [2 ]
Zivkovic, M. [3 ]
Kostic, V. S. [1 ]
机构
[1] Clin Ctr Serbia, Sch Med, Inst Neurol, Belgrade 11000, Serbia
[2] Univ Belgrade, Sch Med, Inst Epidemiol, Belgrade 11001, Serbia
[3] Clin Ctr Nis, Dept Neurol, Nish, Serbia
关键词
Stroke; Acute; Women; Thrombolysis; Outcome; TISSUE-PLASMINOGEN ACTIVATOR; SEX-BASED DIFFERENCES; OUTCOMES; GENDER; TRIAL; CLASSIFICATION; FIBRINOLYSIS; ASPIRIN;
D O I
10.1016/j.clineuro.2009.06.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The female sex is associated with increased stroke severity and relatively poor functional recovery. Several studies have demonstrated that women with stroke benefit more from intravenous thrombolysis compared with men, while others found the nullification of gender effect among women treated with recombinant tissue plasminogen activator (rtPA). The purpose of our study was to determine any gender differences in the efficacy and safety of systemic thrombolysis among patients with acute ischemic stroke in Serbia. Methods: Data were from the Serbian experience with intravenous thrombolysis in ischemic stroke (SETIS) study, a prospective, ongoing, multicenter, open, and observational study in Serbia of all patients who have received rtPA for acute ischemic stroke. We analyzed sex differences in the baseline characteristics, functional outcome and treatment complications. Results: Among 60 women and 96 men with stroke and treated with intravenous thrombolysis, we found that at day 90, no significant sex differences in excellent functional outcome (50.9% of women vs. 57.0% of men, p = 0.5), favorable functional outcome (61.4% of women vs. 68.8% of men, p = 0.38) or death (8.8% of women vs. 12.9% of men, p = 0.60). These results were constant even after adjustments for age, severity of basal neurological deficit and onset to treatment time. Conclusion: There were no sex differences in functional outcome at 90 days after the stroke among patients treated with IV rtPA. This finding might confirm that thrombolytic therapy nullifies usual sex differences in stroke outcome and suggests that women with stroke may benefit more from rtPA treatment. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:729 / 732
页数:4
相关论文
共 18 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION [J].
BAMFORD, J ;
SANDERCOCK, P ;
DENNIS, M ;
BURN, J ;
WARLOW, C .
LANCET, 1991, 337 (8756) :1521-1526
[3]   Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy [J].
Barber, PA ;
Demchuk, AM ;
Zhang, JJ ;
Buchan, AM .
LANCET, 2000, 355 (9216) :1670-1674
[4]   Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke [J].
Elkind, M. S. V. ;
Prabhakaran, S. ;
Pittman, J. ;
Koroshetz, W. ;
Jacoby, M. ;
Johnston, K. C. .
NEUROLOGY, 2007, 68 (11) :842-848
[5]   Influence of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients [J].
Fernandez-Cadenas, I. ;
Alvarez-Sabin, J. ;
Ribo, M. ;
Rubiera, M. ;
Mendioroz, M. ;
Molina, C. A. ;
Rosell, A. ;
Montaner, J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (09) :1862-1868
[6]   FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY [J].
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :129-135
[7]   Sex-based differences in the effect of intra-arterial treatment of stroke - Analysis of the PROACT-2 study [J].
Hill, Michael D. ;
Kent, David M. ;
Hinchey, Judith ;
Rowley, Howard ;
Buchan, Alastair M. ;
Wechsler, Lawrence R. ;
Higashida, Randall T. ;
Fischbein, Nancy J. ;
Dillon, William P. ;
Gent, Michael ;
Firszt, Carolyn M. ;
Schulz, Gregory A. ;
Furlan, Anthony J. .
STROKE, 2006, 37 (09) :2322-2325
[8]   Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke [J].
Kain, K ;
Carter, AM ;
Bamford, JM ;
Grant, PJ ;
Catto, AJ .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (02) :390-392
[9]   The gender effect in stroke thrombolysis - Of CASES, controls, and treatment-effect modification [J].
Kent, David M. ;
Buchan, Alastair M. ;
Hill, Michael D. .
NEUROLOGY, 2008, 71 (14) :1080-1083
[10]   Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke - A pooled analysis of randomized clinical trials [J].
Kent, DM ;
Price, LL ;
Ringleb, P ;
Hill, MD ;
Selker, HP .
STROKE, 2005, 36 (01) :62-65